The fifth annual edition of Scientific American Worldview explores ongoing challenges and opportunities in the biopharmaceutical industry, including the looming potential of an “innovation cliff.”
Many experts believe that biotechnology remains in its infancy, leaving room for growth. The overall volatility makes it difficult to accurately assess trends within individual countries, but the mission of Worldview is to create an increasingly precise picture of the evolution of biotechnology innovation around the world.
One of the world’s greatest challenges – hunger – inspired this year’s profiles, which highlight three leaders in agricultural biotechnology.
Country Spotlights feature biotechnology stories from around the world, including a collaboration between Costa Rica and Spain, draught resistant tea in Malawi, biotechnology meetings in Egypt and the United Arab Emirates, among others.
This year’s issue boasts the longest list of countries in the Scientific American Worldview Scorecard. Our first Scorecard, published in 2009, analyzed 36 countries, while this year’s version has expanded to include 54. That increase reflects the ongoing development of the field itself.
The Worldview Scorecard’s growing history provides companies, countries and other biotechnology stakeholders with useful data to assess potential collaborations. The recent growth in collaborative activities parallels indications of potential industry recovery reported in the 2012 Scorecard.
This year’s data revisits that topic to see if the global biotechnology sector really is on the upswing, or if early indicators merely reflected a blip in those data. Blip or not, the expansion of the Scorecard’s list of countries, industry statistics and the continuing trend toward collaboration all indicate growth in a range of biotechnology sectors. Don’t miss this the Scientific American Worldview Super Session at the 2013 BIO International Convention to learn more and pick up a hard copy of the issue.